Correlates of Protection for Cholera

Abstract A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this associati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases Jg. 224; H. Supplement_7; S. S732 - S737
Hauptverfasser: Iyer, Anita S, Harris, Jason B
Format: Journal Article
Sprache:Englisch
Veröffentlicht: US Oxford University Press 20.12.2021
Schlagworte:
ISSN:0022-1899, 1537-6613, 1537-6613
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Abstract A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this association. While cholera toxin is a dominant target of the human antibody response to Vibrio cholerae infection, antitoxin responses are not associated with long-term immunity, and are not effective CoPs for cholera. Instead, protection appears to be mediated by functional antibodies that target the O-polysaccharide coated V. cholerae outer membrane. Vibriocidal antibodies, which are complement-dependent bactericidal antibodies, remain the most accepted CoP for cholera and are used as surrogate end points in some vaccine studies. However, the association between vibriocidal antibody titers and immunity is not absolute, and they are unlikely to reflect a mechanistic correlate of protection against cholera.
AbstractList Abstract A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this association. While cholera toxin is a dominant target of the human antibody response to Vibrio cholerae infection, antitoxin responses are not associated with long-term immunity, and are not effective CoPs for cholera. Instead, protection appears to be mediated by functional antibodies that target the O-polysaccharide coated V. cholerae outer membrane. Vibriocidal antibodies, which are complement-dependent bactericidal antibodies, remain the most accepted CoP for cholera and are used as surrogate end points in some vaccine studies. However, the association between vibriocidal antibody titers and immunity is not absolute, and they are unlikely to reflect a mechanistic correlate of protection against cholera.
A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this association. While cholera toxin is a dominant target of the human antibody response to Vibrio cholerae infection, antitoxin responses are not associated with long-term immunity, and are not effective CoPs for cholera. Instead, protection appears to be mediated by functional antibodies that target the O-polysaccharide coated V. cholerae outer membrane. Vibriocidal antibodies, which are complement-dependent bactericidal antibodies, remain the most accepted CoP for cholera and are used as surrogate end points in some vaccine studies. However, the association between vibriocidal antibody titers and immunity is not absolute, and they are unlikely to reflect a mechanistic correlate of protection against cholera.
A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this association. While cholera toxin is a dominant target of the human antibody response to Vibrio cholerae infection, antitoxin responses are not associated with long-term immunity, and are not effective CoPs for cholera. Instead, protection appears to be mediated by functional antibodies that target the O-polysaccharide coated V. cholerae outer membrane. Vibriocidal antibodies, which are complement-dependent bactericidal antibodies, remain the most accepted CoP for cholera and are used as surrogate end points in some vaccine studies. However, the association between vibriocidal antibody titers and immunity is not absolute, and they are unlikely to reflect a mechanistic correlate of protection against cholera.A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However, the degree to which a CoP can serve as a surrogate end point for vaccine efficacy should depend on the robustness of this association. While cholera toxin is a dominant target of the human antibody response to Vibrio cholerae infection, antitoxin responses are not associated with long-term immunity, and are not effective CoPs for cholera. Instead, protection appears to be mediated by functional antibodies that target the O-polysaccharide coated V. cholerae outer membrane. Vibriocidal antibodies, which are complement-dependent bactericidal antibodies, remain the most accepted CoP for cholera and are used as surrogate end points in some vaccine studies. However, the association between vibriocidal antibody titers and immunity is not absolute, and they are unlikely to reflect a mechanistic correlate of protection against cholera.
Author Iyer, Anita S
Harris, Jason B
Author_xml – sequence: 1
  givenname: Anita S
  surname: Iyer
  fullname: Iyer, Anita S
  organization: Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
– sequence: 2
  givenname: Jason B
  surname: Harris
  fullname: Harris, Jason B
  email: jbharris@mgh.harvard.edu
  organization: Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34668561$$D View this record in MEDLINE/PubMed
BookMark eNo9kDtPwzAYRS1URB-wMqIMDDCE-hG_RhTxkirBALPlxJ9FqjQudjLw75uqgekO9-hK9yzRrAsdIHRN8APBmq2bzrsmrbeNrQotz9CCcCZzIQiboQXGlOZEaT1Hy5S2GOOCCXmB5qwQQnFBFui2DDFCa3tIWfDZRww91H0TusyHmJXfoYVoL9G5t22CqylX6Ov56bN8zTfvL2_l4yavC077nDrlgXnCXeEKTKSSilYEW-8VKBBUSlDKOVdZXY0gk1xrLwXj0mlBtWArdHfa3cfwM0Dqza5JNbSt7SAMyVCujruS0RG9mdCh2oEz-9jsbPw1f89G4P4EhGH_3xJsjtbMyZqZrLEDKXBflA
CitedBy_id crossref_primary_10_15585_mmwr_rr7102a1
crossref_primary_10_3390_ijerph19127141
crossref_primary_10_1093_cei_uxae124
crossref_primary_10_3390_microorganisms12040727
crossref_primary_10_1038_s41385_022_00574_z
crossref_primary_10_1093_infdis_jiaf382
crossref_primary_10_1146_annurev_micro_041320_033201
crossref_primary_10_3201_eid2909_230174
crossref_primary_10_3389_fimmu_2025_1641319
ContentType Journal Article
Copyright The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021
The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
Copyright_xml – notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. 2021
– notice: The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
DBID TOX
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1093/infdis/jiab497
DatabaseName Oxford Journals Open Access Collection
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
DocumentTitleAlternate Enteric Diseases and Nutritional Disorders: Persisting Challenges for LMICs
EISSN 1537-6613
EndPage S737
ExternalDocumentID 34668561
10.1093/infdis/jiab497
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI099243
GroupedDBID ---
-DZ
-~X
..I
.2P
.55
.GJ
.I3
.XZ
.ZR
08P
0R~
123
1KJ
1TH
29K
2AX
2WC
36B
3O-
4.4
41~
48X
53G
5GY
5RE
5VS
5WD
6.Y
70D
85S
AABZA
AACGO
AACZT
AAHBH
AAHTB
AAJKP
AAJQQ
AAMVS
AANCE
AAOGV
AAPGJ
AAPNW
AAPQZ
AAPXW
AAQQT
AARHZ
AASNB
AAUAY
AAUQX
AAVAP
AAWDT
AAWTL
AAYOK
ABBHK
ABEUO
ABIXL
ABJNI
ABKDP
ABLJU
ABNHQ
ABNKS
ABOCM
ABPEJ
ABPLY
ABPPZ
ABPTD
ABQLI
ABQNK
ABSAR
ABSMQ
ABTLG
ABWST
ABXSQ
ABXVV
ABZBJ
ACFRR
ACGFO
ACGFS
ACGOD
ACMRT
ACPQN
ACPRK
ACUFI
ACUTJ
ACUTO
ACYHN
ACZBC
ADACV
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADULT
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKPW
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEUPB
AEWNT
AEXZC
AFFNX
AFFZL
AFHKK
AFIYH
AFOFC
AFSHK
AFXAL
AFXEN
AFYAG
AGINJ
AGKEF
AGKRT
AGMDO
AGQXC
AGSYK
AGUTN
AHMBA
AHXPO
AI.
AIAGR
AIJHB
AJEEA
ALMA_UNASSIGNED_HOLDINGS
ALUQC
APIBT
APJGH
APWMN
AQDSO
AQKUS
AQVQM
ATGXG
AVNTJ
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BR6
BTRTY
BVRKM
BZKNY
C45
CDBKE
CS3
CZ4
D-I
DAKXR
DCCCD
DIK
DILTD
DOOOF
DU5
D~K
EBS
ECGQY
EE~
EIHJH
EJD
EMOBN
ENERS
ESX
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
G8K
GAUVT
GJXCC
GX1
H13
H5~
HAR
HQ3
HTVGU
HW0
HZ~
IH2
IOX
IPSME
J21
J5H
JAAYA
JBMMH
JENOY
JHFFW
JKQEH
JLS
JLXEF
JPM
JSG
JSODD
JST
KAQDR
KBUDW
KOP
KQ8
KSI
KSN
L7B
LSO
LU7
M49
MBLQV
MHKGH
MJL
ML0
MVM
N4W
N9A
NEJ
NGC
NOMLY
NOYVH
NU-
NVLIB
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
O~Y
P0-
P2P
PAFKI
PEELM
PQQKQ
Q1.
Q5Y
QBD
RD5
ROX
ROZ
RUSNO
RW1
RXO
SA0
SJN
TCURE
TEORI
TJX
TMA
TOX
TR2
VH1
W2D
W8F
WH7
X7H
X7M
Y6R
YAYTL
YKOAZ
YXANX
ZE2
ZGI
ZKG
ZXP
~91
ABDFA
ABEJV
ABGNP
ABVGC
AHMMS
CGR
CUY
CVF
ECM
EIF
NPM
YIF
7X8
ABPQP
ADNBA
AEMQT
AHGBF
AJBYB
AJNCP
ALXQX
JXSIZ
ID FETCH-LOGICAL-c452t-2d8fe3f15d4d40178782b10aff8e8e6277e88dddba9bfe337599f76357d962963
IEDL.DBID TOX
ISICitedReferencesCount 11
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000741773000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0022-1899
1537-6613
IngestDate Sun Sep 28 11:28:22 EDT 2025
Wed Feb 19 02:27:25 EST 2025
Wed Aug 28 03:17:22 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue Supplement_7
Keywords cholera vaccines
correlates of protection
cholera
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c452t-2d8fe3f15d4d40178782b10aff8e8e6277e88dddba9bfe337599f76357d962963
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://dx.doi.org/10.1093/infdis/jiab497
PMID 34668561
PQID 2584017732
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2584017732
pubmed_primary_34668561
oup_primary_10_1093_infdis_jiab497
PublicationCentury 2000
PublicationDate 2021-12-20
PublicationDateYYYYMMDD 2021-12-20
PublicationDate_xml – month: 12
  year: 2021
  text: 2021-12-20
  day: 20
PublicationDecade 2020
PublicationPlace US
PublicationPlace_xml – name: US
– name: United States
PublicationTitle The Journal of infectious diseases
PublicationTitleAlternate J Infect Dis
PublicationYear 2021
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
SSID ssj0004367
Score 2.4375968
Snippet Abstract A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease....
A correlate of protection (CoP) is a measured adaptive immune response to vaccination or infection that is associated with protection against disease. However,...
SourceID proquest
pubmed
oup
SourceType Aggregation Database
Index Database
Publisher
StartPage S732
SubjectTerms Adaptive Immunity
Antibodies, Bacterial - immunology
Cholera - prevention & control
Cholera Toxin - immunology
Cholera Vaccines - adverse effects
Cholera Vaccines - immunology
Humans
Vaccine Efficacy
Vibrio cholerae - immunology
Vibrio cholerae O1 - immunology
Title Correlates of Protection for Cholera
URI https://www.ncbi.nlm.nih.gov/pubmed/34668561
https://www.proquest.com/docview/2584017732
Volume 224
WOSCitedRecordID wos000741773000005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LS8NAEB60qHjxUV_1UaL0Guo-so-jFIuX1h4q5BY23Q1UJJWmFfz3ziZphepBLznlsTs7k_2G2fk-gI62kRc9MiEnloc85SRUlpIwlYhGqBWUWl6KTcjhUMWxHtVk0cUvJXzNumhpOy26r1OTcu37xkmkvEePn-PvDkgm5IoXnGAKsaZn3Hx8o4_tB5wst5X-4T8GdAQHNXYMHqrFPoYtlzdht1KT_GzC3qCuk59Ap-dFN948jgxmWTCqyBhwCQLEqEHPa-LOzSm89B_Hvaew1kMIJzyii5BalTmWkchyi2kRhpqiKbk3WaaccoJK6ZSy1qZGp3gjk5HWWUk4Z7WgGGln0MhnubuAwIqU3etUYLpEOHFUZw53rcgYSvBPLLMW3KGZkveK8SKpKtUsqWae1DNvwe3Kigk6pa80mNzNlkVCEdbgACWjLTivzLt-F-NCKERtl3_5xBXsU3-IhFAM52toLOZLdwM7k4_FtJi3YVvGCq_D0aBd-sMXQCqvWA
linkProvider Oxford University Press
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Correlates+of+Protection+for+Cholera&rft.jtitle=The+Journal+of+infectious+diseases&rft.au=Iyer%2C+Anita+S&rft.au=Harris%2C+Jason+B&rft.date=2021-12-20&rft.pub=Oxford+University+Press&rft.issn=0022-1899&rft.eissn=1537-6613&rft.volume=224&rft.issue=Supplement_7&rft.spage=S732&rft.epage=S737&rft_id=info:doi/10.1093%2Finfdis%2Fjiab497&rft.externalDocID=10.1093%2Finfdis%2Fjiab497
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1899&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1899&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1899&client=summon